Carl-Johan Ekman

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: JOURNAL OF ECT. 2024;40(2):88-95
Electroconvulsive Therapy Versus Repetitive Transcranial Magnetic Stimulation in Patients With a Depressive Episode
Strandberg P; Nordenskjold A; Boden R; Ekman CJ; Lundberg J; Popiolek K
Article: INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH. 2023;32(4):e1960
Mapping length of inpatient treatment duration and year-wise relapse rates in eating disordered populations in a well-defined Western-European healthcare region across 1998-2020
Andersson P; Jamshidi E; Ekman C-J; Tedroff K; Bjorkander J; Sjogren M; Lundberg J; Jokinen J; Bostrom ADE
Article: JOURNAL OF ECT. 2023;39(4):227-234
Anorexia Nervosa With Comorbid Severe Depression
Andersson P; Jamshidi E; Ekman C-J; Tedroff K; Bjorkander J; Sjogren M; Lundberg J; Jokinen J; Desai Bostrom AE
Article: JOURNAL OF AFFECTIVE DISORDERS. 2023;329:50-54
Outcome of transcranial magnetic intermittent theta-burst stimulation in the treatment of depression-A Swedish register-based study
Ekman CJ; Popiolek K; Boden R; Nordenskjold A; Lundberg J
Article: NORDIC JOURNAL OF PSYCHIATRY. 2022;76(2):96-103
Validity of diagnoses, treatment dates, and rating scales in the Swedish national quality register for electroconvulsive therapy
Ahmad I; Sandberg M; Brus O; Ekman CJ; Hammar A; Landen M; Lundberg J; Nordanskog P; von Knorring L; Nordenskjold A
Article: JOURNAL OF AFFECTIVE DISORDERS. 2021;290:240-244
P11 (S100A10) as a potential predictor of ketamine response in patients with SSRI-resistant depression
Veldman ER; Mamula D; Jiang H; Tiger M; Ekman C-J; Lundberg J; Svenningsson P
Article: MEDICINE (UNITED KINGDOM). 2021;100(14):e25273
Repetitive transcranial magnetic stimulation in major depression A three-arm parallel-group dose-response randomized pilot trial
Johansson K; Adler M; Bave U; Ekman C-J; Lundberg J
Article: FRONTIERS IN NEUROSCIENCE. 2021;15:698633
Plasma Levels of Brain-Derived Neurotrophic Factor and S100B in Relation to Antidepressant Response to Ketamine
Jiang H; Veldman ER; Tiger M; Ekman C-J; Lundberg J; Svenningsson P
Article: JOURNAL OF ECT. 2020;36(4):242-246
Electroconvulsive Therapy in Depression Improvement in Quality of Life Depending on Age and Sex
Guney P; Ekman CJ; Hammar A; Heintz E; Landen M; Lundberg J; Nordanskog P; Nordenskjold A
Article: JOURNAL OF ECT. 2020;36(4):272-278
The Effect of Pulse Width on Subjective Memory Impairment and Remission Rate 6 Months After Electroconvulsive Therapy
Tornhamre E; Ekman CJ; Hammar A; Landen M; Lundberg J; Nordanskog P; Nordenskjold A
Article: JOURNAL OF ECT. 2020;36(3):168-171
The Incidence of Dental Fracturing in Electroconvulsive Therapy in Sweden
Goeterfelt L; Ekman CJ; Hammar A; Landen M; Lundberg J; Nordanskog P; Nordenskjoeld A
Article: NORDIC JOURNAL OF PSYCHIATRY. 2020;74(5):359-365
Physician estimated vs. self-reported subjective memory in depressed patients treated with electroconvulsive therapy
Stengard J; Ekman CJ; Bave U; Lundahl A; Abawi M; Adler M; Landen M; Lundberg J
Article: TRANSLATIONAL PSYCHIATRY. 2020;10(1):159
A randomized placebo-controlled PET study of ketamine′s effect on serotonin_1B receptor binding in patients with SSRI-resistant depression
Tiger M; Veldman ER; Ekman C-J; Halldin C; Svenningsson P; Lundberg J
Article: BIOLOGICAL PSYCHIATRY. 2020;87(3):271-281
Longitudinal Cortical Thickness Changes in Bipolar Disorder and the Relationship to Genetic Risk, Mania, and Lithium Use
Abe C; Liberg B; Song J; Bergen SE; Petrovic P; Ekman CJ; Sellgren CM; Ingvar M; Landen M
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2018;138(4):325-335
Bipolar disorder type I and II show distinct relationships between cortical thickness and executive function
Abe C; Rolstad S; Petrovic P; Ekman C-J; Sparding T; Ingvar M; Landen M
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2018;115(22):E5154-E5163
Mapping cortical brain asymmetry in 17,141 healthy individuals worldwide via the ENIGMA Consortium
Kong X-Z; Mathias SR; Guadalupe T; Glahn DC; Franke B; Crivello F; Tzourio-Mazoyer N; Fisher SE; Thompson PM; Francks C
Article: MOLECULAR PSYCHIATRY. 2018;23(4):932-942
Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group
Hibar DP; Westlye LT; Doan NT; Jahanshad N; Cheung JW; Ching CRK; Versace A; Bilderbeck AC; Uhlmann A; Mwangi B; Kraemer B; Overs B; Hartberg CB; Abe C; Dima D; Grotegerd D; Sprooten E; Boen E; Jimenez E; Howells FM; Delvecchio G; Temmingh H; Starke J; Almeida JRC; Goikolea JM; Houenou J; Beard LM; Rauer L; Abramovic L; Bonnin M; Ponteduro MF; Keil M; Rive MM; Yao N; Yalin N; Najt P; Rosa PG; Redlich R; Trost S; Hagenaars S; Fears SC; Alonso-Lana S; van Erp TGM; Nickson T; Chaim-Avancini TM; Meier TB; Elvsashagen T; Haukvik UK; Lee WH; Schene AH; Lloyd AJ; Young AH; Nugent A; Dale AM; Pfennig A; McIntosh AM; Lafer B; Baune BT; Ekman CJ; Zarate CA; Bearden CE; Henry C; Simhandl C; McDonald C; Bourne C; Stein DJ; Wolf DH; Cannon DM; Glahn DC; Veltman DJ; Pomarol-Clotet E; Vieta E; Canales-Rodriguez EJ; Nery FG; Duran FLS; Busatto GF; Roberts G; Pearlson GD; Goodwin GM; Kugel H; Whalley HC; Ruhe HG; Soares JC; Fullerton JM; Rybakowski JK; Savitz J; Chaim KT; Fatjo-Vilas M; Soeiro-de-Souza MG; Boks MP; Zanetti MV; Otaduy MCG; Schaufelberger MS; Alda M; Ingvar M; Phillips ML; Kempton MJ; Bauer M; Landen M; Lawrence NS; van Haren NEM; Horn NR; Freimer NB; Gruber O; Schofield PR; Mitchell PB; Kahn RS; Lenroot R; Machado-Vieira R; Ophoff RA; Sarro S; Frangou S; Satterthwaite TD; Hajek T; Dannlowski U; Malt UF; Arolt V; Gattaz WF; Drevets WC; Caseras X; Agartz I; Thompson PM; Andreassen OA
Article: BRAIN, BEHAVIOR, AND IMMUNITY. 2017;65:195-201
Markers of neuroinflammation and neuronal injury in bipolar disorder: Relation to prospective clinical outcomes
Isgren A; Sellgren C; Ekman C-J; Holmen-Larsson J; Blennow K; Zetterberg H; Jakobsson J; Landen M
Article: COGNITIVE NEUROPSYCHIATRY. 2017;22(5):407-421
Classification of cognitive performance in bipolar disorder
Sparding T; Silander K; Palsson E; Ostlind J; Ekman CJ; Sellgren CM; Joas E; Hansen S; Landen M
Article: SCHIZOPHRENIA BULLETIN. 2017;43(1):99-107
A History of Psychosis in Bipolar Disorder is Associated With Gray Matter Volume Reduction
Ekman CJ; Petrovic P; Johansson AGM; Sellgren C; Ingvar M; Landen M
Article: MOLECULAR PSYCHIATRY. 2016;21(12):1710-1716
Subcortical volumetric abnormalities in bipolar disorder
Hibar DP; Westlye LT; van Erp TGM; Rasmussen J; Leonardo CD; Faskowitz J; Haukvik UK; Hartberg CB; Doan NT; Agartz I; Dale AM; Gruber O; Kraemer B; Trost S; Liberg B; Abe C; Ekman CJ; Ingvar M; Landen M; Fears SC; Freimer NB; Bearden CE; Sprooten E; Glahn DC; Pearlson GD; Emsell L; Kenney J; Scanlon C; McDonald C; Cannon DM; Almeida J; Versace A; Caseras X; Lawrence NS; Phillips ML; Dima D; Delvecchio G; Frangou S; Satterthwaite TD; Wolf D; Houenou J; Henry C; Malt UF; Boen E; Elvsashagen T; Young AH; Lloyd AJ; Goodwin GM; Mackay CE; Bourne C; Bilderbeck A; Abramovic L; Boks MP; van Haren NEM; Ophoff RA; Kahn RS; Bauer M; Pfennig A; Alda M; Hajek T; Mwangi B; Soares JC; Nickson T; Dimitrova R; Sussmann JE; Hagenaars S; Whalley HC; McIntosh AM; Thompson PM; Andreassen OA
Article: MOLECULAR PSYCHIATRY. 2016;21(11):1504-1510
Cerebrospinal fluid metabolomics identifies a key role of isocitrate dehydrogenase in bipolar disorder: evidence in support of mitochondrial dysfunction hypothesis
Yoshimi N; Futamura T; Bergen SE; Iwayama Y; Ishima T; Sellgren C; Ekman CJ; Jakobsson J; Palsson E; Kakumoto K; Ohgi Y; Yoshikawa T; Landen M; Hashimoto K
Article: MOLECULAR PSYCHIATRY. 2016;21(10):1342-1350
A genome-wide association study of kynurenic acid in cerebrospinal fluid: implications for psychosis and cognitive impairment in bipolar disorder
Sellgren CM; Kegel ME; Bergen SE; Ekman CJ; Olsson S; Larsson M; Vawter MP; Backlund L; Sullivan PF; Sklar P; Smoller JW; Magnusson PKE; Hultman CM; Walther-Jallow L; Svensson CI; Lichtenstein P; Schalling M; Engberg G; Erhardt S; Landen M
Article: SOCIAL COGNITIVE AND AFFECTIVE NEUROSCIENCE. 2016;11(7):1041-1049
Significant grey matter changes in a region of the orbitofrontal cortex in healthy participants predicts emotional dysregulation
Petrovic P; Ekman CJ; Klahr J; Tigerstrom L; Ryden G; Johansson AGM; Sellgren C; Golkar A; Olsson A; Ohman A; Ingvar M; Landen M
Article: JOURNAL OF PSYCHIATRY & NEUROSCIENCE. 2016;41(4):240-250
Cortical thickness, volume and surface area in patients with bipolar disorder types I and II
Abe C; Ekman C-J; Sellgren C; Petrovic P; Ingvar M; Landen M
Article: COGNITIVE NEUROPSYCHIATRY. 2016;21(3):271-278
Polymorphisms of BDNF and CACNA1C are not associated with cognitive functioning in bipolar disorder or healthy controls
Rolstad S; Majkowitz CS; Joas E; Ekman CJ; Palsson E; Landen M
Article: BIPOLAR DISORDERS. 2015;17(8):859-868
Polymorphisms of dopamine pathway genes NRG1 and LMX1A are associated with cognitive performance in bipolar disorder
Rolstad S; Palsson E; Ekman CJ; Eriksson E; Sellgren C; Landen M
Article: BRAIN. 2015;138(Pt 11):3440-3448
Manic episodes are related to changes in frontal cortex: a longitudinal neuroimaging study of bipolar disorder 1
Abe C; Ekman C-J; Sellgren C; Petrovic P; Ingvar M; Landen M
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2015;25(8):1091-1098
CSF neuroinflammatory biomarkers in bipolar disorder are associated with cognitive impairment
Rolstad S; Jakobsson J; Sellgren C; Isgren A; Ekman CJ; Bjerke M; Blennow K; Zetterberg H; Palsson E; Landen M
Article: JOURNAL OF PSYCHIATRY & NEUROSCIENCE. 2015;40(4):250-258
Monocyte and microglial activation in patients with mood-stabilized bipolar disorder
Jakobsson J; Bjerke M; Sahebi S; Isgren A; Ekman CJ; Sellgren C; Olsson B; Zetterberg H; Blennow K; Palsson E; Landen M
Article: BRAIN IMAGING AND BEHAVIOR. 2015;9(2):333-341
Subcortical morphometry and psychomotor function in euthymic bipolar disorder with a history of psychosis
Liberg B; Ekman CJ; Sellgren C; Johansson AG; Landen M
Article: PLOS ONE. 2015;10(5):e0127100
Cognitive Performance and Cerebrospinal Fluid Biomarkers of Neurodegeneration: A Study of Patients with Bipolar Disorder and Healthy Controls
Rolstad S; Jakobsson J; Sellgren C; Ekman C-J; Blennow K; Zetterberg H; Palsson E; Landen M
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2015;25(1):133-140
Markers of glutamate signaling in cerebrospinal fluid and serum from patients with bipolar disorder and healthy controls
Palsson E; Jakobsson J; Sodersten K; Fujita Y; Sellgren C; Ekman C-J; Agren H; Hashimoto K; Landen M
Article: PLOS ONE. 2015;10(1):e0115562
Cognitive Functioning in Clinically Stable Patients with Bipolar Disorder I and II
Sparding T; Silander K; Palsson E; Ostlind J; Sellgren C; Ekman CJ; Joas E; Hansen S; Landen M
Article: BRAIN, BEHAVIOR, AND IMMUNITY. 2015;43:198-204
Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic treatment
Isgren A; Jakobsson J; Palsson E; Ekman CJ; Johansson AGM; Sellgren C; Blennow K; Zetterberg H; Landen M
Article: NEUROPSYCHOPHARMACOLOGY. 2014;39(10):2349-2356
Elevated Concentrations of Neurofilament Light Chain in the Cerebrospinal Fluid of Bipolar Disorder Patients
Jakobsson J; Bjerke M; Ekman CJ; Sellgren C; Johansson AGM; Zetterberg H; Blennow K; Landen M
Article: PSYCHIATRY RESEARCH. 2014;217(3):143-146
Blood-cerebrospinal fluid barrier dysfunction in patients with bipolar disorder in relation to antipsychotic treatment
Zetterberg H; Jakobsson J; Redsater M; Andreasson U; Palsson E; Ekman CJ; Sellgren C; Johansson AGM; Blennow K; Landen M
Article: BRAIN IMAGING AND BEHAVIOR. 2014;8(2):153-182
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data
Thompson PM; Stein JL; Medland SE; Hibar DP; Vasquez AA; Renteria ME; Toro R; Jahanshad N; Schumann G; Franke B; Wright MJ; Martin NG; Agartz I; Alda M; Alhusaini S; Almasy L; Almeida J; Alpert K; Andreasen NC; Andreassen OA; Apostolova LG; Appel K; Armstrong NJ; Aribisala B; Bastin ME; Bauer M; Bearden CE; Bergmann O; Binder EB; Blangero J; Bockholt HJ; Boen E; Bois C; Boomsma DI; Booth T; Bowman IJ; Bralten J; Brouwer RM; Brunner HG; Brohawn DG; Buckner RL; Buitelaar J; Bulayeva K; Bustillo JR; Calhoun VD; Cannon DM; Cantor RM; Carless MA; Caseras X; Cavalleri GL; Chakravarty MM; Chang KD; Ching CRK; Christoforou A; Cichon S; Clark VP; Conrod P; Coppola G; Crespo-Facorro B; Curran JE; Czisch M; Deary IJ; de Geus EJC; den Braber A; Delvecchio G; Depondt C; de Haan L; de Zubicaray GI; Dima D; Dimitrova R; Djurovic S; Dong H; Donohoe G; Duggirala R; Dyer TD; Ehrlich S; Ekman CJ; Elvsashagen T; Emsell L; Erk S; Espeseth T; Fagerness J; Fears S; Fedko I; Fernandez G; Fisher SE; Foroud T; Fox PT; Francks C; Frangou S; Frey EM; Frodl T; Frouin V; Garavan H; Giddaluru S; Glahn DC; Godlewska B; Goldstein RZ; Gollub RL; Grabe HJ; Grimm O; Gruber O; Guadalupe T; Gur RE; Gur RC; Goering HHH; Hagenaars S; Hajek T; Hall GB; Hall J; Hardy J; Hartman CA; Hass J; Hatton SN; Haukvik UK; Hegenscheid K; Heinz A; Hickie IB; Ho B-C; Hoehn D; Hoekstra PJ; Hollinshead M; Holmes AJ; Homuth G; Hoogman M; Hong LE; Hosten N; Hottenga J-J; Pol HEH; Hwang KS; Jack CRJ; Jenkinson M; Johnston C; Joensson EG; Kahn RS; Kasperaviciute D; Kelly S; Kim S; Kochunov P; Koenders L; Kraemer B; Kwok JBJ; Lagopoulos J; Laje G; Landen M; Landman BA; Lauriello J; Lawrie SM; Lee PH; Le Hellard S; Lemaitre H; Leonardo CD; Li C-S; Liberg B; Liewald DC; Liu X; Lopez LM; Loth E; Lourdusamy A; Luciano M; Macciardi F; Machielsen MWJ; MacQueen GM; Malt UF; Mandl R; Manoach DS; Martinot J-L; Matarin M; Mather KA; Mattheisen M; Mattingsdal M; Meyer-Lindenberg A; McDonald C; McIntosh AM; McMahon FJ; McMahon KL; Meisenzahl E; Melle I; Milaneschi Y; Mohnke S; Montgomery GW; Morris DW; Moses EK; Mueller BA; Munoz Maniega S; Muehleisen TW; Mueller-Myhsok B; Mwangi B; Nauck M; Nho K; Nichols TE; Nilsson L-G; Nugent AC; Nyberg L; Olvera RL; Oosterlaan J; Ophoff RA; Pandolfo M; Papalampropoulou-Tsiridou M; Papmeyer M; Paus T; Pausova Z; Pearlson GD; Penninx BW; Peterson CP; Pfennig A; Phillips M; Pike GB; Poline J-B; Potkin SG; Puetz B; Ramasamy A; Rasmussen J; Rietschel M; Rijpkema M; Risacher SL; Roffman JL; Roiz-Santianez R; Romanczuk-Seiferth N; Rose EJ; Royle NA; Rujescu D; Ryten M; Sachdev PS; Salami A; Satterthwaite TD; Savitz J; Saykin AJ; Scanlon C; Schmaal L; Schnack HG; Schork AJ; Schulz SC; Schuer R; Seidman L; Shen L; Shoemaker JM; Simmons A; Sisodiya SM; Smith C; Smoller JW; Soares JC; Sponheim SR; Sprooten E; Starr JM; Steen VM; Strakowski S; Strike L; Sussmann J; Saemann PG; Teumer A; Toga AW; Tordesillas-Gutierrez D; Trabzuni D; Trost S; Turner J; Van den Heuvel M; van der Wee NJ; van Eijk K; van Erp TGM; van Haren NEM; van 't Ent D; van Tol M-J; Hernandez MCV; Veltman DJ; Versace A; Voelzke H; Walker R; Walter H; Wang L; Wardlaw JM; Weale ME; Weiner MW; Wen W; Westlye LT; Whalley HC; Whelan CD; White T; Winkler AM; Wittfeld K; Woldehawariat G; Wolf C; Zilles D; Zwiers MP; Thalamuthu A; Schofield PR; Freimer NB; Lawrence NS; Drevets W
Article: PSYCHIATRY RESEARCH. 2014;221(3):173-178
Vertex-based morphometry in euthymic bipolar disorder implicates striatal regions involved in psychomotor function
Liberg B; Ekman CJ; Sellgren C; Johansson A; Landen M
Article: BMC PSYCHIATRY. 2013;13:165
Neurocognitive function in bipolar disorder: a comparison between bipolar I and II disorder and matched controls
Palsson E; Figueras C; Johansson AGM; Ekman C-J; Hultman B; Ostlind J; Landen M
Article: JOURNAL OF PSYCHIATRY & NEUROSCIENCE. 2013;38(4):E21-E26
Decreased cerebrospinal fluid secretogranin II concentrations in severe forms of bipolar disorder
Jakobsson J; Stridsberg M; Zetterberg H; Blennow K; Ekman C-J; Johansson AGM; Sellgren C; Landen M
Article: NEUROPSYCHOPHARMACOLOGY. 2013;38(4):664-672
Altered Concentrations of Amyloid Precursor Protein Metabolites in the Cerebrospinal Fluid of Patients with Bipolar Disorder
Jakobsson J; Zetterberg H; Blennow K; Ekman CJ; Johansson AGM; Landen M
Article: PLOS ONE. 2012;7(9):e45994
Microscopic Particles in Two Fractions of Fresh Cerebrospinal Fluid in Twins with Schizophrenia or Bipolar Disorder and in Healthy Controls
Johansson V; Nybom R; Wetterberg L; Hultman CM; Cannon TD; Johansson AGM; Ekman CJ; Landen M
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2010;122(6):507-515
Manic episodes are associated with grey matter volume reduction - a voxel-based morphometry brain analysis
Ekman CJ; Lind J; Ryden E; Ingvar M; Landen M
Article: SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY. 2003;38(12):684-689
Use of antidepressants in deliberate self-poisoning: psychiatric diagnoses and drugs used between 1987 and 1997 in Lund, Sweden.
Bäckman J; Ekman C-J; Alsén M; Ekedahl A; Träskman-Bendz L
Visa fler

Alla övriga publikationer

Letter: JOURNAL OF ECT. 2024;40(2):140-141
Electroconvulsive Therapy Versus Repetitive Transcranial Magnetic Stimulation in Patients With a Depressive Episode: A Register-Based Study
Popiolek K; Arnison T; Boden R; Ekman CJ; Lundberg J; Strandberg P; Nordenskjold A
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S193-S194
The genetic risk for bipolar disorder predicts cortical thickness of the medial orbitofrontal cortex in patients and healthy controls
Abe C; Ossler W; Liberg B; Song J; Sarah B; Petrovic P; Ekman CJ; Sellgren C; Ingvar M; Landen M
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S341
Large-scale serum biomarker profiling in patients with bipolar disorder
Palsson E; Jakobsson J; Isgren A; Sellgren C; Ekman CJ; Holmen-Larsson J; Landen M
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2014;24:S429-S430
Microglial activation in mood stabilised bipolar disorder patients
Jakobsson J; Isgren A; Palsson E; Ekman CJ; Johansson AGM; Sellgren C; Blennow K; Zetterberg H; Landen M
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2014;24:S426
Cerebrospinal fluid biomarkers of neurodegeneration affect cognitive functions in bipolar disorder but not healthy controls
Rolstad S; Jakobsson J; Sparding T; Sellgren C; Ekman CJ; Blennow KAJ; Zetterberg H; Palson E; Landen M
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2014;24:S423-S424
Sense of coherence as a predictor of suicide attempts in bipolar disorder
Palsson E; Lundberg U; Johnson L; Ekman CJ; Sellgren C; Landen M
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2014;24:S441
Altered insular-prefrontal network in bipolar disorder
Ekman C; Petrovic P; Ingvar M; Landen M
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2013;23:S385-S386
Cerebrospinal fluid cytokine concentrations in bipolar disorder patients and healthy controls
Isgren A; Jakobsson J; Palsson E; Ekman CJ; Johansson A; Sellgren C; Blennow K; Zetterberg H; Landen M
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2013;23:S376-S377
Associations between cerebrospinal fluid markers and on-going medical treatment in patients with bipolar disorder
Jakobsson J; Palsson E; Bjerke M; Olsson B; Ekman CJ; Sellgren C; Johansson AGM; Blennow K; Zetterberg H; Landen M
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2013;23:S94-S95
Cerebrospinal fluid biomarkers of brain injury in bipolar disorder
Jakobsson J; Palsson E; Ekman CJ; Sellgren C; Johansson AGM; Zetterberg H; Blennow K; Landen M
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2012;22:S289-S290
Neurocognitive function in bipolar disorder: a comparison between bipolar I and II disorder and matched controls
Palsson E; Figueras C; Johansson A; Ekman CJ; Hultman B; Landen M
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2012;22:S283
Exploratory analysis of biomarkers in the cerebrospinal fluid of bipolar patients
Jakobsson J; Zetterberg H; Blennow K; Ekman CJ; Johansson AGM; Landen M

Anställningar

Adjungerad Adjunkt, Klinisk neurovetenskap, Karolinska Institutet, 2024-2026

Examina och utbildning

Medicine Doktorsexamen, Institutionen för klinisk neurovetenskap, Karolinska Institutet, 2016

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI